Oncotelic Therapeutics Inc
(OTLC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 36,271 | 24,735 | 7,005 | 8,797 | 7,752 |
| Other current assets | 18 | 41 | 67 | 129 | 33 |
| TOTAL | $36,739 | $25,144 | $7,165 | $9,098 | $8,155 |
| Non-Current Assets | |||||
| PPE Net | 28 | 32 | 36 | 5 | 8 |
| Intangibles | 47 | 70 | 93 | 118 | 142 |
| Other Non-Current Assets | 33 | 0 | 0 | 0 | 0 |
| TOTAL | $108 | $102 | $129 | $123 | $150 |
| Total Assets | $36,847 | $25,246 | $7,294 | $9,221 | $8,305 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 849 | 432 | 476 | 733 | 430 |
| Accrued Expenses | 916 | 515 | 433 | 202 | 30 |
| TOTAL | $1,948 | $1,395 | $1,251 | $1,515 | $891 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,948 | $1,395 | $1,251 | $1,515 | $891 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 20,706 | 15,301 | 15,236 | 3,134 | 2,639 |
| Common Shares | 207 | 153 | 56 | 30 | 23 |
| Retained earnings | -245,067 | -241,138 | -238,508 | -236,411 | -231,447 |
| TOTAL | $34,899 | $23,851 | $6,043 | $7,706 | $7,414 |
| Total Liabilities And Equity | $36,847 | $25,246 | $7,294 | $9,221 | $8,305 |